You are here

Women's Health

Is Merck a Better Buy After Announcing Spinoff?

Is Merck a Better Buy After Announcing Spinoff?

Motley Fool

Flag link:

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

Stat

Flag link:

[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension

[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension

CP WIre

Duke University

Flag link:

[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension

Duke University

Flag link:

AHA: Caladrius single injection helps heart disease that hits women the hardest

AHA: Caladrius single injection helps heart disease that hits women the hardest

Fierce Biotech

Caladrius Biosciences

Flag link:

One health care startup at a time, this venture capitalist wants to harness the investing power of women

One health care startup at a time, this venture capitalist wants to harness the investing power of women

Stat

venture capital

Flag link:

Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health

Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health

Endpoints

vaginal microbiome

Flag link:

Apple recently hired a prominent obstetrician, signaling interest in women's health

Apple recently hired a prominent obstetrician, signaling interest in women's health

CNBC

Flag link:

Evotec and Ferring Team Up to Work on Women's Health Issues

Evotec and Ferring Team Up to Work on Women's Health Issues

CP Wire

small molecule drugs

Flag link:

Allergan plans sales of women's health, infectious disease units

Allergan plans sales of women's health, infectious disease units

Reuters

infectious diseases

Flag link:

Allergan toys with $5B women's health sale to boost bottom-feeding shares

Allergan toys with $5B women's health sale to boost bottom-feeding shares

Fierce Pharma

Flag link:

Teva closes $703m sale of global women’s health biz to CVC Capital

Teva closes $703m sale of global women’s health biz to CVC Capital

Drug Delivery Business News

Teva Pharmaceutical

Flag link:

Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report

Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report

Endpoints

Flag link:

Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline

Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline

Endpoints

Flag link:

Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS

Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS

Stat

healthcare reform

Flag link:

Allergan could sell women's health for $6B, if it would only agree to split: analyst

Allergan could sell women's health for $6B, if it would only agree to split: analyst

Fierce Pharma

Flag link:

Cash-strapped Teva closes in on women's health sale No. 2: report

Cash-strapped Teva closes in on women's health sale No. 2: report

Fierce Pharma

Teva Pharmaceutical

Flag link:

Bidders line up for Teva's women's health unit in potential $2B sale

Bidders line up for Teva's women's health unit in potential $2B sale

Fierce Pharma

Teva Pharmaceutical

Flag link:

Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe

Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe

GoInPharma

Teva Pharmaceutical

pain management

Flag link:

Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology

Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology

GoInPharma

Teva Pharmaceutical

Flag link:

Pages